Lv11
80 积分 2020-12-06 加入
Discovery of CBPD-409 as a Highly Potent, Selective, and Orally Efficacious CBP/p300 PROTAC Degrader for the Treatment of Advanced Prostate Cancer
2小时前
待确认
Heteroaryl Glutarimides and Dihydrouracils as Cereblon Ligand Scaffolds for Molecular Glue Degrader Discovery
14天前
已完结
Protein degraders push into novel target space
1个月前
已完结
Relocalizing transcriptional kinases to activate apoptosis
1个月前
已完结
Targeted Delivery of AR-V7 siRNA with Bivalent PSMA Aptamers Effectively Suppresses the Growth of Enzalutamide-Resistant Prostate Cancer
1个月前
已完结
Discovery of the First Clinical Protein Degrader for the Treatment of Autoimmune Indications: Orally Bioavailable and Selective IRAK4 Degrader KT-474
1个月前
已完结
Diastereoselective cycloaddition of chiral 1-acryloyl-2-imidazolidinone and o-quinodimethane generated by reduction of 1,2-bis(bromomethyl)benzene with zinc
2个月前
已完结
Structural and Physicochemical Features of Oral PROTACs
4个月前
已完结
Discovery of a Series of Orally Bioavailable Androgen Receptor Degraders for the Treatment of Prostate Cancer
4个月前
已完结
The state of the art of PROTAC technologies for drug discovery
5个月前
已完结
皖公网安备34019202002308
